Terms: = Uterine cancer AND EXT2, Q93063, ENSG00000151348, 2132, SOTV AND Treatment
4 results:
1. Phase II trial of vaginal cuff brachytherapy followed by dose-dense chemotherapy in early stage endometrial cancer patients with enriched, high-intermediate risk factors for recurrence.
Castellano T; John Maxwell IV; Adam Walter J; Thompson S; McMeekin DS; Landrum LM
Gynecol Oncol; 2021 Mar; 160(3):669-673. PubMed ID: 33358492
[TBL] [Abstract] [Full Text] [Related]
2. Addressing challenges in future surveillance after surgery for early-stage cervical cancer.
Fuglsang K; Petersen LK; Blaakaer J
Int J Gynecol Cancer; 2015 Feb; 25(2):309-14. PubMed ID: 25594142
[TBL] [Abstract] [Full Text] [Related]
3. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR
Hum Reprod; 2006 Feb; 21(2):545-53. PubMed ID: 16210385
[TBL] [Abstract] [Full Text] [Related]
4. Cervical cancer prevention in remote rural Nicaragua: a program evaluation.
Howe SL; Vargas DE; Granada D; Smith JK
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S232-5. PubMed ID: 16198400
[TBL] [Abstract] [Full Text] [Related]
